Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMTE.L Regulatory News (AMTE)

  • There is currently no data for AMTE

Re Directorate

31 Oct 2022 07:00

RNS Number : 5744E
AMTE Power PLC
31 October 2022
 

31 October 2022

AMTE Power Plc

("AMTE Power" or the "Company")

 

Re Directorate

 

Following the announcement on Tuesday 6 September regarding the appointment of Alan Hollis to the Board of AMTE Power, the Company is pleased to confirm that in line with that announcement, Alan today assumes the role and full responsibilities of Chief Executive Officer.

 

Alan Hollis has a 20 year public company track record of developing and executing profitable growth strategies within engineering and manufacturing businesses with turnovers ranging from £4m-£200m.

 

As previously announced, Kevin Brundish today becomes Strategy Director and remains a member of the Board. His focus will be to continue developing AMTE Power's high performance battery cells in addition to the Company's customer, supplier and Government relationships.

 

ENDS

 

Enquiries:

 

AMTE Power plc

David Morgan (Chairman)

+44 (0)1847 867 200

WH Ireland Limited (NOMAD and Joint Broker)

Chris Fielding / James Bavister / Ben Good (Corporate Finance)

+44 (0)207 220 1666

Panmure Gordon (UK) Limited (Joint Broker)

John Prior / James Sinclair-Ford / Harriette Johnson (Corporate Finance)

+44 (0)207 886 2500

Hugh Rich (Corporate Broking)

Camarco

Ginny Pulbrook / Rosie Driscoll

+44 (0)203 757 4992

 

 

 

Notes to Editors:

 

AMTE Power was founded in 2013 and is a leading developer and manufacturer of lithium-ion and sodium-ion battery cells for specialist markets. In March 2021, the Company was admitted to trading on the AIM market of the London Stock Exchange. The Company is focused on launching a series of next generation battery cells based on new chemistries and cell structures that are designed to solve key problems in power delivery, energy performance, and safety. These new products are targeted at a range of specialist markets including the electric vehicle industry and energy storage sector.

 

AMTE Power's purpose-built cell manufacturing facility in Thurso, Scotland has the second largest cell manufacturing capacity in the UK and the Company also has a product development team based in Oxford. AMTE Power's proposed state-of-the-art MegaFactory in Dundee, Scotland is expected to be operational and in production by Q3 2025 and be capable of producing over 25,000 high added value batteries per day enabling the Company to rapidly scale up cell production.

For further information visit the Company's website: www.amtepower.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAWPGBWUUPPGBU
Date   Source Headline
6th Oct 20222:00 pmRNSPrice Monitoring Extension
6th Oct 20227:00 amRNSAMTE Power agrees contract with UKBIC
6th Sep 20227:00 amRNSDirectorate Change
5th Sep 20227:00 amRNSBoard Change
23rd Aug 20227:00 amRNSOperational and Trading Update
5th Aug 20227:00 amRNSMoU with Cosworth to Supply UHP Cells
29th Jul 202211:00 amRNSPrice Monitoring Extension
28th Jul 202211:05 amRNSSecond Price Monitoring Extn
28th Jul 202211:00 amRNSPrice Monitoring Extension
28th Jul 20227:00 amRNSSelection of preferred site for first MegaFactory
13th Jul 20227:00 amRNSMoU with MAHLE Powertrain to supply UHP cells
7th Jun 20227:00 amRNSMoU signed with Viritech to supply UHP cells
19th May 20227:00 amRNSPDMR Dealing and Holding(s) in Company
10th May 20227:00 amRNSAppointment of Joint Broker
29th Apr 20227:00 amRNSBlock Listing Six Monthly Return
12th Apr 20222:26 pmRNSAMTE Power partners with Sprint Power and Eltrium
31st Mar 20227:00 amRNSPDMR Dealing and Holding(s) in Company
28th Mar 20229:00 amRNSAgreed changes to Concert Party
14th Mar 20224:41 pmRNSSecond Price Monitoring Extn
14th Mar 20224:36 pmRNSPrice Monitoring Extension
10th Mar 20227:00 amRNSOrder for AMTE's sodium-ion cells
10th Mar 20227:00 amRNSHalf Year Update
17th Feb 20227:00 amRNSNotice of Half Year Results
31st Jan 20227:00 amRNSAppointment of Communications Advisers
16th Dec 20217:00 amRNSConfirmation of Grant Award
17th Nov 20211:30 pmRNSResult of AGM
17th Nov 20217:00 amRNSAGM Statement
10th Nov 20217:00 amRNSPDMR Dealing and Holding(s) in Company
9th Nov 20217:00 amRNSCOP26 Engagement and Award of Grant
1st Nov 20217:00 amRNSBlock listing Interim Review
22nd Oct 20213:30 pmRNSPosting of Annual Report and Notice of AGM
5th Oct 20217:00 amRNSFinal Results
4th Oct 20217:00 amRNSAustralian Joint Venture
29th Sep 202111:30 amRNSNotice of Results
24th Sep 20217:00 amRNSDirectorate Change
26th Aug 20212:05 pmRNSSecond Price Monitoring Extn
26th Aug 20212:00 pmRNSPrice Monitoring Extension
18th Aug 202110:30 amRNSPartner in New Government Electric Vehicle Project
16th Jul 20217:00 amRNSTrading Update
24th Jun 20217:00 amRNSAppointed to Lead New Government EV Project
9th Jun 20217:00 amRNSDirectorate Change
10th May 202111:00 amRNSHolding(s) in Company
30th Apr 20217:00 amRNSBlock Listing Application
26th Mar 20214:41 pmRNSSecond Price Monitoring Extn
26th Mar 20214:35 pmRNSPrice Monitoring Extension
23rd Mar 20217:00 amRNSHalf-year Report
19th Mar 20217:00 amRNSHolding(s) in Company
17th Mar 20217:00 amRNSGreen Economy Mark
17th Mar 20217:00 amRNSHolding(s) in Company
15th Mar 20214:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.